| Meanwhile, Covid has been a driver of growth in the UK pharmaceuticals sector. In Cramlington, contract manufacturer Sterling Pharma solutions has seen huge revenue growth and profits to match on the back of new client wins.
This week, the specialist maker of life saving medicines for the global market told Coreena Ford that it was motoring on with an investment programme that has boosted numbers at its North East site to 650 - with more recruitment in the works.
And later this year, the firm is also expecting to complete the acquisition of the 111-acre Novartis Ringaskiddy campus near Cork in Ireland. The purchase will mean Sterling employs more than 1,000 people across its UK, Europe and US facilities. Read Coreena's story here.
|
